A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2011
10/06/2011	US20110244021 Antimicrobial and immunostimulating composition
10/06/2011	US20110244020 Drug condensation aerosols and kits
10/06/2011	US20110244019 Absorbent fabric implant
10/06/2011	US20110244018 Decontaminant edible product, methods of production and uses thereof
10/06/2011	US20110244016 Medical implant having a coating composed of or containing at least one active substance
10/06/2011	US20110244013 Microporous material from ethylene-chlorotrifluoroethylene copolymer and method for making same
10/06/2011	US20110244010 Medical devices including medicaments and methods of making and using same
10/06/2011	US20110244005 Controlled release cgrp delivery composition for cardiovascular and renal indications
10/06/2011	US20110244004 Antifungal composition with enhanced bioavailability
10/06/2011	US20110244003 Self Standing Nanoparticle Networks/Scaffolds with Controllable Void Dimensions
10/06/2011	US20110244002 Mesoporous material excipients for poorly aqueous soluble ingredients
10/06/2011	US20110244001 System and method for the release of nitric oxide using nanoscale media
10/06/2011	US20110243999 Methods and compositions for the treatment of ocular disorders
10/06/2011	US20110243998 Patch preparation and production method thereof
10/06/2011	US20110243997 Film-form preparation and method for producing the same
10/06/2011	US20110243996 Spray freeze dry of compositions for intranasal administration
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243856 Permeable Mixtures, Methods and Compositions for the Skin
10/06/2011	US20110243848 Star polymers, methods of preparation thereof, and uses thereof
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	US20110240022 Aerosol forming device for use in inhalation therapy
10/06/2011	US20110240014 Substrates for drug delivery device and methods of preparing and use
10/06/2011	US20110240013 Method of forming an aerosol for inhalation delivery
10/06/2011	DE102010009071A1 Preparing edible film useful for oral bioactivator, involves dissolving polyethylene glycol and sugar in water, and adding and mixing glycerol with polyethylene glycol-sugar solution
10/06/2011	CA2830052A1 Injectable dendrimer hydrogel nanoparticles
10/06/2011	CA2796567A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration
10/06/2011	CA2795291A1 An insulin conjugate using an immunoglobulin fragment
10/06/2011	CA2795257A1 Pharmaceutical formulations for the treatment of overactive bladder
10/06/2011	CA2795158A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/06/2011	CA2795154A1 Thermogelling anaesthetic compositions
10/06/2011	CA2795050A1 Method for preserving alum adjuvants and alum-adjuvanted vaccines
10/06/2011	CA2795043A1 Humanized il-25 antibodies
10/06/2011	CA2794999A1 Animal feed for calves for conditioning the intestinal flora
10/06/2011	CA2794960A1 Supercritical fluid treatment of high molecular weight biopolymers
10/06/2011	CA2794958A1 Injectable drug delivery formulation
10/06/2011	CA2794956A1 Medical devices including medicaments and methods of making and using same
10/06/2011	CA2794941A1 Process for preparing carrier particles for dry powders for inhalation
10/06/2011	CA2794790A1 Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis
10/06/2011	CA2794734A1 Transdermal delivery patch
10/06/2011	CA2794628A1 Stabilized antibody preparations and uses thereof
10/06/2011	CA2794280A1 Bioadhesive compositions of local anaesthetics
10/06/2011	CA2793974A1 Methods of treating cancer
10/06/2011	CA2793777A1 Formulations of mazindol
10/06/2011	CA2793485A1 A fast dissolving pharmaceutical composition
10/06/2011	CA2793405A1 A fast dissolving pharmaceutical composition
10/06/2011	CA2793222A1 Stabilized formulations of cns compounds
10/06/2011	CA2792352A1 Modified release dosage form comprising desvenlafaxine or salts thereof
10/05/2011	EP2371959A2 Treatment of neurodegenerative disease through intracranial delivery of siRNA
10/05/2011	EP2371854A2 Induction of tumor immunity by variants of folate binding protein
10/05/2011	EP2371394A1 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
10/05/2011	EP2371392A1 Calicheamicin derivative-carrier conjugates
10/05/2011	EP2371379A2 New formulation for increasing bioavailability of neurturin
10/05/2011	EP2371368A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions
10/05/2011	EP2371365A1 Compositions comprising an epothilone and production methods
10/05/2011	EP2371360A2 Selegiline-containing adhesive preparation
10/05/2011	EP2371359A2 Selegiline-containing adhesive preparation
10/05/2011	EP2371358A1 Film-form preparation and method for producing the same
10/05/2011	EP2371357A1 Oral formulations and lipophilic salts of methylnaltrexone
10/05/2011	EP2371356A1 Multi-particle pharmaceutical formulation for colon absorption
10/05/2011	EP2371355A2 Preparations of phospholipids and pharmaceuticals containing-5-amino salicyclic acid for the treatment of inflammatory bowel disease
10/05/2011	EP2371354A1 Film-form preparation and method for producing the same
10/05/2011	EP2371353A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
10/05/2011	EP2371352A2 Devices including protein matrix materials and methods of making and using thereof
10/05/2011	EP2371351A1 Pharmaceutical composition for the treatment of solar urticaria
10/05/2011	EP2371350A1 Foam formulas for treating animal skin illnesses
10/05/2011	EP2370115A1 Hydrogel sponges, methods of producing them and uses thereof
10/05/2011	EP2370081A1 Pharmaceutical compositions containing testosterone and an aromatase inhibitor
10/05/2011	EP2370073A1 Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration
10/05/2011	EP2370069A1 Antioxidant compositions for soft oral tissue and methods of formulation and use there
10/05/2011	EP2370068A2 Methods and compositions for delivery of medicaments to the lungs
10/05/2011	EP2370067A1 Antiviral patch
10/05/2011	EP2370066A1 Method for manufacturing capsule series, and related capsule series
10/05/2011	EP2370065A1 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic
10/05/2011	EP2370064A1 Methods for enhancing stability of polyorthoesters and their formulations
10/05/2011	EP2370063A2 Flowable pharmaceutical depot
10/05/2011	EP2370062A1 Formulations for systemic buccal delivery comprising s- adenosylmethionine, their preparation and use
10/05/2011	EP2370061A2 Pharmaceutical composition comprising ezetimibe and simvastatin
10/05/2011	EP2370060A2 Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
10/05/2011	EP2370059A1 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
10/05/2011	EP2370058A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
10/05/2011	EP2370057A1 Topical herbal formulation for treatment of acne and skin disorders
10/05/2011	EP2370056A2 Enema preparations and their use
10/05/2011	EP2370055A2 Polymeric pharmaceutical dosage form in sustained release
10/05/2011	EP2370054A2 Contact lens drug delivery device
10/05/2011	EP2370053A1 Novel powdered crystalline medicines for inhalation
10/05/2011	EP2369944A1 Protein particles and their use in food
10/05/2011	EP2369923A1 Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
10/05/2011	EP2129377B1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
10/05/2011	EP2117534B1 A pharmaceutical composition with atorvastatin active ingredient
10/05/2011	EP1948245B1 Compositions and their uses for gene therapy of bone conditions
10/05/2011	EP1920786B1 Oral preparation for measuring pyrimidine metabolic capacity
10/05/2011	EP1885343B1 Oral drug compliance monitoring using radio frequency identification tags
10/05/2011	EP1804772B1 Granules comprising a non-steroidal anti-inflammatory drug and a sugar alcohol made by melt extrusion
10/05/2011	EP1706415B1 Lipid- derivatized bisphosphonic acid
10/05/2011	EP1687267B1 Modified mscl protein channel
10/05/2011	EP1680144B1 Methylphenidate solution and associated methods of administration and production
10/05/2011	EP1646366B1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process
10/05/2011	EP1463497B1 Treating muscle wasting with selective androgen receptor modulators
10/05/2011	EP1406633B1 Enhanced drug delivery in transdermal systems
10/05/2011	EP1377276B1 Timed pulse release composition

1 ... 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 ... 2991